Other Species / Isoforms
  FOXN3 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S8-p
MGPVMPPsKKPESsG
0 2
FOXN3 (human) MGPVMPPsKKPESsG S8-p
FOXN3 (mouse) MGPVMPAsKKAESSG S8-p
FOXN3 (rat) MGPVMPASKKPESSG S8
S14-p
PsKKPESsGISVSSG
0 1
FOXN3 (human) PsKKPESsGISVSSG S14-p
FOXN3 (mouse) AsKKAESSGISVSSG S14
FOXN3 (rat) ASKKPESSGISVSSG S14
K70-ub
LNWLHESkNLLKSFG
0 1
FOXN3 (human) LNWLHESkNLLKSFG K70-ub
FOXN3 (mouse) LNWLHESKNLLKSFG K70
FOXN3 (rat) LNWLHESKNLLKSFG K70
S83-p
FGESVLRsVsPVQDL
Upstream
Downstream
1 5
Effects on Modified Protein
  • activity, induced
  • molecular association, regulation
  • protein degradation
  • ubiquitination
Effects on Biological Processes:
  • signaling pathway regulation
Kinase, in vitro:
  • P38A (human)
Putative in vivo kinases:
  • P38A (human)
Regulatory protein:
  • hnRNP U (human)
Treatment
  • SB203580
  • siRNA
FOXN3 (human) FGESVLRsVsPVQDL S83-p
FOXN3 (mouse) FGESVLRsVsPVQDL S83-p
FOXN3 (rat) FGESVLRSVsPVQDL S83
S85-p
ESVLRsVsPVQDLDD
Upstream
Downstream
1 15
Effects on Modified Protein
  • activity, induced
  • molecular association, regulation
  • protein degradation
  • ubiquitination
Effects on Biological Processes:
  • signaling pathway regulation
Kinase, in vitro:
  • P38A (human)
Putative in vivo kinases:
  • P38A (human)
Regulatory protein:
  • hnRNP U (human)
Treatment
  • SB203580
  • siRNA
FOXN3 (human) ESVLRsVsPVQDLDD S85-p
FOXN3 (mouse) ESVLRsVsPVQDLDD S85-p
FOXN3 (rat) ESVLRSVsPVQDLDD S85-p
S97-p
LDDDTPPsPAHsDMP
0 12
FOXN3 (human) LDDDTPPsPAHsDMP S97-p
FOXN3 (mouse) LDDDTPPsPAHsDMP S97-p
FOXN3 (rat) LDDDTPPSPAHSDMP S97
S101-p
TPPsPAHsDMPYDAR
0 2
FOXN3 (human) TPPsPAHsDMPYDAR S101-p
FOXN3 (mouse) TPPsPAHsDMPyDAR S101-p
FOXN3 (rat) TPPSPAHSDMPYDAR S101
Y105
PAHsDMPYDARQNPN
0 1
FOXN3 (human) PAHsDMPYDARQNPN Y105
FOXN3 (mouse) PAHsDMPyDARQNPN Y105-p
FOXN3 (rat) PAHSDMPYDARQNPN Y105
K170-ub
RHNLSLNkCFKKVDK
0 1
FOXN3 (human) RHNLSLNkCFKKVDK K170-ub
FOXN3 (mouse) RHNLSLNKCFKKVDK K170
FOXN3 (rat) RHNLSLNKCFKKVDK K170
K185-ub
ERSQSIGkGSLWCID
0 1
FOXN3 (human) ERSQSIGkGSLWCID K185-ub
FOXN3 (mouse) ERSQSIGKGSLWCID K185
FOXN3 (rat) ERSQSIGKGSLWCID K185
T297-p
GVRPLPItPIGVTAA
0 8
FOXN3 (human) GVRPLPItPIGVTAA T297-p
FOXN3 (mouse) GVRPLPITPIGMTAA T267
FOXN3 (rat) GARPLPITPIGMTAA T267
T316-p
ITSCRMRtEsEPSCG
0 2
FOXN3 (human) ITSCRMRtEsEPSCG T316-p
FOXN3 (mouse) ITSCRMRTESEPPCG T286
FOXN3 (rat) ITSCRVRTESEPPCG T286
S318-p
SCRMRtEsEPSCGsP
0 4
FOXN3 (human) SCRMRtEsEPSCGsP S318-p
FOXN3 (mouse) SCRMRTESEPPCGSP S288
FOXN3 (rat) SCRVRTESEPPCGSP S288
S324-p
EsEPSCGsPVVSGDP
0 5
FOXN3 (human) EsEPSCGsPVVSGDP S324-p
FOXN3 (mouse) ESEPPCGSPVVSGDP S294
FOXN3 (rat) ESEPPCGSPVVSGDP S294
S349-p
SSNARSTsPTSDSIS
0 3
FOXN3 (human) SSNARSTsPTSDSIS S349-p
FOXN3 (mouse) SSTARSTsPTSDSIS S319-p
FOXN3 (rat) SSNARSTSPTSDSIS S319
S391
FRSHESPSDTEEDDR
0 1
FOXN3 (human) FRSHESPSDTEEDDR S391
FOXN3 (mouse) FQSHESHsEPEEEDR S358-p
FOXN3 (rat) FQSHESHSEPEEDDR S358
S412-p
PKDSLGDsGYASQHK
0 4
FOXN3 (human) PKDSLGDsGYASQHK S412-p
FOXN3 (mouse) GKDALGDSGYASQHK S379
FOXN3 (rat) GKDALGDSGYASQHR S379
S432-p
AKARKVPsDTLPLKK
0 1
FOXN3 (human) AKARKVPsDTLPLKK S432-p
FOXN3 (mouse) AKARKVPSDTLPLKK S399
FOXN3 (rat) AKARKVPSDTLPLKK S399
T442
LPLKKRRTEKPPEsD
0 1
FOXN3 (human) LPLKKRRTEKPPEsD T442
FOXN3 (mouse) LPLKKRRtEKPPEsD T409-p
FOXN3 (rat) LPLKKRRTEKPPEsD T409
S448-p
RTEKPPEsDDEEMKE
0 9
FOXN3 (human) RTEKPPEsDDEEMKE S448-p
FOXN3 (mouse) RtEKPPEsDDEEMKE S415-p
FOXN3 (rat) RTEKPPEsDDEEMKE S415-p